RAPID ORAL DESENSITIZATION TO TRIMETHOPRIM-SULFAMETHOXAZOLE (TMP-SMZ) - USE IN PROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS WHO WERE PREVIOUSLY INTOLERANT TO TMP-SMZ

被引:76
作者
GLUCKSTEIN, D [1 ]
RUSKIN, J [1 ]
机构
[1] KAISER PERMANENTE MED CTR,DEPT INTERNAL MED,DIV INFECT DIS,LOS ANGELES,CA 90027
关键词
D O I
10.1093/clinids/20.4.849
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Trimethoprim-sulfamethoxazole (TMP-SMZ) is the drug of choice as prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS. However, adverse reactions ascribed to TMP-SMZ are common in such patients. We previously described a rapid method of oral TMP-SMZ desensitization in patients with AIDS and varying degrees of intolerance to the drug, To assess the feasibility, safety, and long-term clinical utility of our desensitization protocol, we retrospectively studied 22 consecutive patients who underwent desensitization. Prior to the procedure each of the study subjects had exhibited moderate to severe reactions to TMP-SMZ. Desensitization was successfully completed in 19 (86%) of the patients. The three patients for whom desensitization failed experienced chills and/or vomiting that resolved promptly with symptomatic therapy. One of the 19 patients was unavailable for long-term follow-up. Of the remaining 18 patients, three discontinued taking TMP-SMZ within 2 weeks of desensitization because of macular rash and fever. The other 15 (71%) of the evaluable patients tolerated both desensitization and subsequent prophylaxis and took TMP-SMZ for a mean of 14 months (in some cases, for as long as 41 months). None had P. carinii pneumonia while receiving TMP-SMZ. These results indicate that most patients who are presumed to be TMP-SMZ-intolerant can be rapidly desensitized with oral TMP-SMZ and subsequently receive the drug for protracted periods as effective prophylaxis for P. carinii pneumonia.
引用
收藏
页码:849 / 853
页数:5
相关论文
共 46 条
[1]   SEVERE HYPERSENSITIVITY REACTION UPON RECHALLENGE WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN A PATIENT WITH AIDS [J].
ARNOLD, PA ;
GUGLIELMO, BJ ;
HOLLANDER, H .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (01) :43-45
[2]   LOW-DOSE TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS FOR TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS [J].
CARR, A ;
TINDALL, B ;
BREW, BJ ;
MARRIOTT, DJ ;
HARKNESS, JL ;
PENNY, R ;
COOPER, DA .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (02) :106-111
[3]   TRIMETHOPRIM-SULFAMETHOXAZOLE APPEARS MORE EFFECTIVE THAN AEROSOLIZED PENTAMIDINE AS SECONDARY PROPHYLAXIS AGAINST PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS [J].
CARR, A ;
TINDALL, B ;
PENNY, R ;
COOPER, DA .
AIDS, 1992, 6 (02) :165-171
[4]   COST AND BENEFIT OF SECONDARY PROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA [J].
CASTELLANO, AR ;
NETTLEMAN, MD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (06) :820-824
[5]   CUTANEOUS DISEASE AND DRUG-REACTIONS IN HIV-INFECTION [J].
COOPMAN, SA ;
JOHNSON, RA ;
PLATT, R ;
STERN, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (23) :1670-1674
[6]   ORAL DESENSITIZATION TO TRIMETHOPRIM-SULFAMETHOXAZOLE IN A PATIENT WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
FINEGOLD, I .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1986, 78 (05) :905-908
[7]   SAFETY AND EFFICACY OF SULFAMETHOXAZOLE AND TRIMETHOPRIM CHEMOPROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN AIDS [J].
FISCHL, MA ;
DICKINSON, GM ;
LAVOIE, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (08) :1185-1189
[8]  
FREEDBERG KA, 1991, J ACQ IMMUN DEF SYND, V4, P521
[9]   SUCCESSFUL TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA WITH TRIMETHOPRIM-SULFAMETHOXAZOLE IN HYPERSENSITIVE AIDS PATIENTS [J].
GIBBONS, RB ;
LINDAUER, JA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (09) :1259-1260
[10]  
GLUCKSTEIN D, 1988, 4TH INT C AIDS STOCK